Literature DB >> 12168735

Catechol-O-methyltransferase polymorphism and endometriosis.

Fritz Wieser1, Rene Wenzl, Clemens Tempfer, Christoph Worda, Johannes Huber, Christian Schneeberger.   

Abstract

PURPOSE: Catechol-O-methyltransferase (COMT) inactivates the estradiol metabolites, 2-hydroxy and 4-hydroxy catechols, which have been implicated in the pathogenesis of endometriosis. A COMT valine to methionine polymorphism (G-to-A) in exon 4 of the COMT gene is polymorphic in the human population, with 25% of Caucasians being homozygous for the low-activity allele (COMT-L) of the enzyme. In a case-control study we investigated whether this COMT polymorphism is associated with endometriosis.
METHODS: Polymerase chain reaction was performed to analyze the COMT genotype among women with surgically and histologically confirmed endometriosis (study group; n = 91) and in women without evidence of endometriosis confirmed by laparoscopy or laparotomy (control group; n = 92).
RESULTS: Allele frequencies for the low-activity allele (COMT-L) among women with endometriosis and controls were 0.50 and 0.50, respectively (p = 0.999; odds ratio = 1.0, 95% CI: 0.66-1.51).
CONCLUSIONS: Our results suggest that the valine to methionine polymorphism in exon 4 of the COMT gene is not associated with the risk of endometriosis compared to a surgical control population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168735      PMCID: PMC3455752          DOI: 10.1023/a:1016062726783

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  29 in total

1.  Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

Authors:  P A Thompson; P G Shields; J L Freudenheim; A Stone; J E Vena; J R Marshall; S Graham; R Laughlin; T Nemoto; F F Kadlubar; C B Ambrosone
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

Review 2.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

3.  Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis.

Authors:  H Baranova; M Canis; T Ivaschenko; E Albuisson; R Bothorishvilli; V Baranov; P Malet; M A Bruhat
Journal:  Mol Hum Reprod       Date:  1999-07       Impact factor: 4.025

4.  Association of estrogen receptor gene polymorphisms with endometriosis.

Authors:  I Georgiou; M Syrrou; I Bouba; N Dalkalitsis; M Paschopoulos; I Navrozoglou; D Lolis
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

Review 5.  Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.

Authors:  S E Bulun; K M Zeitoun; K Takayama; H Sasano
Journal:  J Mol Endocrinol       Date:  2000-08       Impact factor: 5.098

6.  Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues.

Authors:  S E Bulun; K M Zeitoun; G Kilic
Journal:  Am J Obstet Gynecol       Date:  2000-04       Impact factor: 8.661

7.  Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse.

Authors:  B C Paria; H Lim; X N Wang; J Liehr; S K Das; S K Dey
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

8.  Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.

Authors:  K Zeitoun; K Takayama; H Sasano; T Suzuki; N Moghrabi; S Andersson; A Johns; L Meng; M Putman; B Carr; S E Bulun
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

9.  Cloning of a factor required for activity of the Ah (dioxin) receptor.

Authors:  E C Hoffman; H Reyes; F F Chu; F Sander; L H Conley; B A Brooks; O Hankinson
Journal:  Science       Date:  1991-05-17       Impact factor: 47.728

Review 10.  Heritability and molecular genetic studies of endometriosis.

Authors:  F Z Bischoff; J L Simpson
Journal:  Hum Reprod Update       Date:  2000 Jan-Feb       Impact factor: 15.610

View more
  6 in total

1.  Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.

Authors:  Britton Trabert; Stephen M Schwartz; Ulrike Peters; Anneclaire J De Roos; Chu Chen; Delia Scholes; Victoria L Holt
Journal:  Fertil Steril       Date:  2011-09-28       Impact factor: 7.329

2.  Aberrant endometrial DNA methylome of homeobox A10 and catechol-O-methyltransferase in endometriosis.

Authors:  Fei Ji; Xinhua Yang; Yan He; Hui Wang; Aixingzi Aili; Yan Ding
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

Review 3.  Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review.

Authors:  Joy-Fleur van der Vaart; Gabriele Susanne Merki-Feld
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

4.  Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis.

Authors:  Yeon Jean Cho; Sung Eun Hur; Ji Young Lee; In Ok Song; Hye-Sung Moon; Mi Kyoung Koong; Hye Won Chung
Journal:  J Assist Reprod Genet       Date:  2007-06-12       Impact factor: 3.412

Review 5.  Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.

Authors:  C B Tempfer; M Simoni; B Destenaves; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2008-09-19       Impact factor: 15.610

6.  Analysis of the relationship between COMT polymorphisms and endometriosis susceptibility.

Authors:  Jiajia Zhai; Lei Jiang; Aiping Wen; Jingde Jia; Lili Zhu; Bo Fan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.